March
2017
Launch
ARM methodology initiated within Link2Trials
First behavioral adherence modeling integrated into trial workflows
You benefit from:
• Higher patient retention and reduced early drop-out
• Stronger protocol adherence and data reliability
• Lower operational burden for sites and sponsors
PACE Clinical delivers the right support to the right patient at the right moment through our Adherence Risk Management (ARM) platform and expert consultancy.
ARM enables adherence to be managed as a measurable performance variable, not an unpredictable patient risk.
First behavioral adherence modeling integrated into trial workflows
Co-development of B-COMPASS computational adherence model
Platform refinement, SaaS architecture, integration with eCOA/ePRO
A dedicated adherence risk management platform & services PACE Clinical is the focused continuation of this journey, transforming validated behavioral science into a scalable adherence intelligence platform.
ARM is a behavior-driven, adherence risk management platform designed specifically for clinical trials.
Rather than reacting to drop-out, ARM predicts adherence risk early and enables targeted, timely intervention.
· Predict: Each participant receives an individualized adherence risk profile at enrollment.
· Personalize: Support adapts to behavioral drivers, health status, and protocol complexity.
· Intervene: Real-time alerts empower sites to act before non-adherence impacts trial outcomes.
• 25–30% average early drop-out in trials
• Up to $36,000 cost per lost patient
• 67% of protocol deviations linked to non-adherence
• $1.6M potential revenue impact per day of delay
Despite years of patient-centric initiatives, drop-out rates remain stable because most solutions rely on generic engagement tools.
True improvement requires behavioral personalization and dynamic risk management.
PACE Clinical transforms adherence from an unpredictable patient risk into a measurable, manageable trial performance driver.
ARM combines:
• Validated behavioral science (SHE & B-COMPASS)
• Digital patient app and web portal
• Continuous risk reassessment and dynamic scoring
• Real-time back-office dashboards for sponsors and sites
• Seamless integration with eCOA/ePRO systems
The result: full visibility into adherence risk across your study population — without increasing site workload.
PACE Clinical is evolving ARM into an intelligent, adaptive adherence ecosystem powered by AI.
Optional capabilities include:
• Enhanced predictive behavioral modeling
• Dynamically generated support pathways
• Intelligent patient interaction interfaces
• Continuous learning across study populations
Our goal is clear: to anticipate adherence risk before it materializes and support patients proactively throughout their clinical journey.
